Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hruby

Showing results (391-400 of 762) with videos related to

Pageof 77
Sort By:
Geroscience|April 29, 2025
Beyond genes and environment: mapping biological stochasticity in agingAdam J Hruby, Gilberto Garcia, Max A Thorwald, et al.
International Journal of Peptide Research and Therapeutics|August 29, 2009
Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin ReceptorsJatinder S Josan, Josef Vagner, Heather L Handl, et al.
Bioorganic & Medicinal Chemistry|November 19, 2021
C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transportersMehr-Un-Nisa, Munawar A Munawar, David Rankin, et al.
Journal of Medicinal Chemistry|May 29, 2009
Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptorHongchang Qu, Minying Cai, Alexander V Mayorov, et al.
Life Sciences|January 1, 1992
Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivityP Horan, R J Tallarida, R C Haaseth, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Characterization of SNF 9007, a novel cholecystokinin/opoid ligand in mouse ileum in vitro: evidence for involvement of cholecystokininA and cholecystokininB receptors in regulation of ion transportR K Rao, S Levenson, S N Fang, et al.
International Journal of Peptide and Protein Research|June 1, 1990
Cholecystokinin analogues with high affinity and selectivity for brain membrane receptorsV J Hruby, S A Fang, R Knapp, et al.
The Journal of Urology|July 29, 1998
Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover studyH Wessells, K Fuciarelli, J Hansen, et al.
Journal of Medicinal Chemistry|June 1, 1973
Solid-phase synthesis of (2-isoleucine, 4-leucine) oxytocin and (2-phenylalanine, 4-leucine) oxytocin and some their pharmacological propertiesV J Hruby, F Muscio, C M Gronginsky, et al.
Life Sciences|January 1, 1992
The metabolic effects of oxytocin are mediated by a uterine type of receptor and are inhibited by oxytocin antagonist and by arginine vasopressin in the dogN Altszuler, C R Rosenberg, B Winkler, et al.
Pageof 77

Showing results (391-400 of 762) with videos related to

Sort By:
Pageof 77
Geroscience|April 29, 2025
Beyond genes and environment: mapping biological stochasticity in agingAdam J Hruby, Gilberto Garcia, Max A Thorwald, et al.
International Journal of Peptide Research and Therapeutics|August 29, 2009
Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin ReceptorsJatinder S Josan, Josef Vagner, Heather L Handl, et al.
Bioorganic & Medicinal Chemistry|November 19, 2021
C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transportersMehr-Un-Nisa, Munawar A Munawar, David Rankin, et al.
Journal of Medicinal Chemistry|May 29, 2009
Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptorHongchang Qu, Minying Cai, Alexander V Mayorov, et al.
Life Sciences|January 1, 1992
Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivityP Horan, R J Tallarida, R C Haaseth, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Characterization of SNF 9007, a novel cholecystokinin/opoid ligand in mouse ileum in vitro: evidence for involvement of cholecystokininA and cholecystokininB receptors in regulation of ion transportR K Rao, S Levenson, S N Fang, et al.
International Journal of Peptide and Protein Research|June 1, 1990
Cholecystokinin analogues with high affinity and selectivity for brain membrane receptorsV J Hruby, S A Fang, R Knapp, et al.
The Journal of Urology|July 29, 1998
Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover studyH Wessells, K Fuciarelli, J Hansen, et al.
Journal of Medicinal Chemistry|June 1, 1973
Solid-phase synthesis of (2-isoleucine, 4-leucine) oxytocin and (2-phenylalanine, 4-leucine) oxytocin and some their pharmacological propertiesV J Hruby, F Muscio, C M Gronginsky, et al.
Life Sciences|January 1, 1992
The metabolic effects of oxytocin are mediated by a uterine type of receptor and are inhibited by oxytocin antagonist and by arginine vasopressin in the dogN Altszuler, C R Rosenberg, B Winkler, et al.
Pageof 77